Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
75 hedge funds and large institutions have $318M invested in Accelerate Diagnostics in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 10 closing their positions.
24% more capital invested
Capital invested by funds: $256M → $318M (+$61.4M)
13% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 23
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 78 → 75 (-3)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
60% less call options, than puts
Call options by funds: $2.01M | Put options by funds: $5.02M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IHM
Iguana Healthcare Management
New York
|
+$4.18M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$4.15M |
| 3 |
MGM
Miura Global Management
New York
|
+$3.45M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$3.02M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Lucus Advisors
New York
|
-$1.53M |
| 2 |
Goldman Sachs
New York
|
-$1.43M |
| 3 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$672K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$629K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$355K |
AXDX Hedge Fund Activity: Q1 2015 in Review
75 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q1 2015, worth a combined $318M — up 24% from $256M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of AXDX and 7 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 26 added.
The largest buyer was Iguana Healthcare Management, adding an estimated $4.18M. The largest seller was Lucus Advisors, exiting entirely with an estimated $1.53M sold.
- 75 institutional investors held Accelerate Diagnostics (AXDX) as of Q1 2015, down from 78 in Q4 2014.
- Funds reported $318M of Accelerate Diagnostics stock for Q1 2015, up 24% quarter-over-quarter.
- 7 funds opened new Accelerate Diagnostics positions in Q1 2015 and 10 closed out, a net change of -3 holders.
- The largest Accelerate Diagnostics buyer in Q1 2015 was Iguana Healthcare Management, an estimated $4.18M added.
- The largest Accelerate Diagnostics seller in Q1 2015 was Lucus Advisors, an estimated $1.53M sold.
Based on aggregated 13F filings for Q1 2015.